ATTENTION TO THE FAMILIES OF SMA TYPE 1 PATIENTS WHO HAVE RECEIVED DRUG APPROVAL FROM THE TURKISH PHARMACEUTICAL AND MEDICAL DEVICE AUTHORITY

Ministry of Health Turkey Pharmaceuticals Attention to families who have received approval from the Medical Devices Agency and will apply to the Social Security Institution! 
The article regarding the supply and payment of the drug containing the active ingredient Nusinersen Sodium, published on 22.10.2018, is below.
Health Application The change made in the communiqué will be published in the Official Gazette in the following days.
In line with the SHFK decision, in order to prevent patient grievance, the parties have been notified to carry out the necessary work and transactions without waiting for the change to be published in the Official Gazette.